Our findings show also that inhibition of FAK in HCC cells might confer protective anticancer effects by decreasing the levels of long-chain Cer (24:0), which is instead upregulated in human HCC and associated with patient survival [31,32]. The gene discussed is PTK2; the disease is hepatocellular carcinoma.